Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Genotypic analysis of patients treated with adefovir dipivoxil

Jan. 31, 1997

Cel-Sci presents results with heteroconjugate technology for HIV vaccine development

Jan. 31, 1997

NCI discloses anti-HIV agent with novel mechanism of action

Jan. 31, 1997

Abbott develops protease inhibitor for combination therapy

Jan. 31, 1997

Thalidomide: Forty years later

Jan. 30, 1997

Cidofovir highlighted at retroviral conference

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Encouraging results reported for Merck anti-HIV combination

Jan. 30, 1997

Triple combination therapy dramatically effective in HIV/AIDS

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...